Nature 434, 913–917 (2005)
Two patent applications (patent numbers US 2005/0143370 and WO 2005/012524, filed in July 2004) with relevance to this work have been filed by Cancer Research Technology Limited and The University of Sheffield and we want to declare our relationship with these patents. N.J.C. and T.H., and T.H. alone, are named inventors on these patents, respectively, but are not owners of the patents nor do they have shares in the companies or institutions to which the patents belong. However, because the value of these patents has increased, owing to further results obtained in other laboratories since publication, N.J.C. and T.H. now wish to declare possible competing financial interests.
Rights and permissions
About this article
Cite this article
Bryant, H., Schultz, N., Thomas, H. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 447, 346 (2007). https://doi.org/10.1038/nature05789
Issue Date:
DOI: https://doi.org/10.1038/nature05789
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.